Systemic Therapy for Melanoma: ASCO Guideline Update Q and A

JCO Oncol Pract. 2024 Feb;20(2):173-177. doi: 10.1200/OP.23.00675. Epub 2023 Dec 1.

Authors

Vernon K Sondak¹, Michael B Atkins², Hans Messersmith³, Anthony Provenzano⁴, Rahul Seth⁵, Sanjiv S Agarwala⁶

Affiliations

¹ H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
² Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC.
³ American Society of Clinical Oncology, Alexandria, VA.
⁴ Columbia Presbyterian Clinical Assoc, Bronxville, NY.
⁵ SUNY Upstate Medical University, Syracuse, NY.
⁶ Lewis Katz School of Medicine at Temple University, Philadelphia, PA.

PMID: 38039436
DOI: 10.1200/OP.23.00675

Abstract

This Q&A answers questions regarding ASCO's recent Systemic Therapy for Melanoma guideline.

MeSH terms

Humans
Medical Oncology*
Melanoma* / drug therapy
Societies, Medical